Correlation Between Amylyx Pharmaceuticals and Edesa Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amylyx Pharmaceuticals and Edesa Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amylyx Pharmaceuticals and Edesa Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amylyx Pharmaceuticals and Edesa Biotech, you can compare the effects of market volatilities on Amylyx Pharmaceuticals and Edesa Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amylyx Pharmaceuticals with a short position of Edesa Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amylyx Pharmaceuticals and Edesa Biotech.

Diversification Opportunities for Amylyx Pharmaceuticals and Edesa Biotech

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Amylyx and Edesa is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Amylyx Pharmaceuticals and Edesa Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edesa Biotech and Amylyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amylyx Pharmaceuticals are associated (or correlated) with Edesa Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edesa Biotech has no effect on the direction of Amylyx Pharmaceuticals i.e., Amylyx Pharmaceuticals and Edesa Biotech go up and down completely randomly.

Pair Corralation between Amylyx Pharmaceuticals and Edesa Biotech

Given the investment horizon of 90 days Amylyx Pharmaceuticals is expected to generate 1.56 times more return on investment than Edesa Biotech. However, Amylyx Pharmaceuticals is 1.56 times more volatile than Edesa Biotech. It trades about -0.01 of its potential returns per unit of risk. Edesa Biotech is currently generating about -0.05 per unit of risk. If you would invest  1,552  in Amylyx Pharmaceuticals on November 9, 2024 and sell it today you would lose (1,177) from holding Amylyx Pharmaceuticals or give up 75.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Amylyx Pharmaceuticals  vs.  Edesa Biotech

 Performance 
       Timeline  
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Amylyx Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's essential indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the ETF investors.
Edesa Biotech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Edesa Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Amylyx Pharmaceuticals and Edesa Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amylyx Pharmaceuticals and Edesa Biotech

The main advantage of trading using opposite Amylyx Pharmaceuticals and Edesa Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amylyx Pharmaceuticals position performs unexpectedly, Edesa Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edesa Biotech will offset losses from the drop in Edesa Biotech's long position.
The idea behind Amylyx Pharmaceuticals and Edesa Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings